Quick Answer
TANDEM DIABETES CARE INC reported Stockholders Equity of $155.17 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed a decrease of -41.0% in Stockholders Equity from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $97.26 million | Q2 2014: $83.55 million | Q3 2014: $67.48 million | Q1 2015: $102.25 million | Q2 2015: $87.75 million | Q3 2015: $71.23 million | Q1 2016: $45.94 million | Q2 2016: $32.07 million | Q3 2016: $5.20 million | Q1 2017: -$1.87 million | Q2 2017: -$18.28 million | Q3 2017: -$27.96 million | Q1 2018: $11.85 million | Q2 2018: $26.00 million | Q3 2018: $115.43 million | Q1 2019: $120.96 million | Q2 2019: $145.35 million | Q3 2019: $166.99 million | Q1 2020: $207.18 million | Q2 2020: $267.70 million | Q3 2020: $326.54 million | Q1 2021: $313.41 million | Q2 2021: $346.09 million | Q3 2021: $389.65 million | Q1 2022: $437.38 million | Q2 2022: $449.58 million | Q3 2022: $421.82 million | Q1 2023: $338.75 million | Q2 2023: $329.23 million | Q3 2023: $314.00 million | Q1 2024: $243.06 million | Q2 2024: $233.88 million | Q3 2024: $237.71 million | Q1 2025: $155.29 million | Q2 2025: $133.28 million | Q3 2025: $132.97 million.
- Over the full 15 years of available data (2011 to 2025), TANDEM DIABETES CARE INC's Stockholders Equity has grown by 317.6%.
- Historical annual values: Fiscal year 2025: $155.17 million | Fiscal year 2024: $263.10 million | Fiscal year 2023: $313.63 million | Fiscal year 2022: $439.95 million | Fiscal year 2021: $433.11 million | Fiscal year 2020: $366.31 million | Fiscal year 2019: $194.98 million | Fiscal year 2018: $131.28 million | Fiscal year 2017: -$29.15 million | Fiscal year 2016: -$5.93 million | Fiscal year 2015: $63.47 million | Fiscal year 2014: $54.57 million | Fiscal year 2013: $115.54 million | Fiscal year 2012: -$106.05 million | Fiscal year 2011: -$71.30 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: